To Study the Effectiveness and Safety of Niacin and a Topical Steroid Eye Drop to Treat Retinal Vein Occlusions

Completed · Phase 2/Phase 3

Conditions studied: Retinal Vein Occlusion

In brief

The purpose of this study is to determine whether Niacin, a B vitamin, may act as a vasodilator to encourage earlier formation of collateral blood vessels that may serve to bypass the obstructed vein in the eye. The topical steroid eye drops are aimed at reducing swelling in the retina, until the collateral vessels have a chance to develop.

Key facts

Study ID

NCT00493064

Run by

Palo Alto Medical Foundation

People needed

63

Starts

2006-10-01

Expected to finish

2016-10-01

Last updated by the study team

2018-12-21

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients must be able to understand the study procedures, agree to participate, and give written consent.
• Patient must have central retinal vein occlusion, hemi-retinal vein occlusion or branch retinal vein occlusion.
• Patients must be able to follow the study medication regimen.
• Patients must agree to return for the once monthly eye exams.
• Patients must agree to have liver function tests performed on a regular basis.
• Patients must agree to have regular appointments with their Internist on an established basis.

You may not qualify if…

• Patients with active Gout, or high levels of Uric
• Patients may not be pregnant or lactating.
• The Principal Investigator reserves the right to exclude any patient who he feels will not make a good candidate.

Where it is running

• Palo Alto Medical Foundation Department of Ophthalmology — Palo Alto, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.